Merck unit to pay $31 mln to settle fraud claims by U.S. states
October 15, 2014 at 16:04 PM EDT
Oct 15, (Reuters) - A subsidiary of Merck & Co has agreed to pay U.S. states $31 million to settle claims that it overcharged their Medicaid programs for an antidepressant it had sold at a discount to pharmacy companies, attorney generals from three states said on Wednesday.